Harwin Peter Evan insider trades
Harwin Peter Evan has filed 22 Form 4s with the SEC that we hold, for Cogent Biosciences, Inc. (COGT) (Director), Apogee Therapeutics, Inc. (APGE) (Director), Crescent Biopharma, INC. (CBIO) (Director, 10% owner) and Spyre Therapeutics, Inc. (SYRE) (Director), among 8 companies in all. Across all of them we count 4 purchases worth $29.7M and 1 sale worth $133.5M reported on Form 4. In the last 12 months: 1 purchase ($18.2M) and 1 sale ($133.5M). The largest single trade was a sale of 1,750,000 shares of Apogee Therapeutics, Inc. worth $133.5M, dated 2026-01-22. The first filing on our record is dated 2022-06-09 and the latest 2026-06-11.
Cogent Biosciences, Inc. (COGT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Apogee Therapeutics, Inc. (APGE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-01-22 | S, sale reported on Form 4 | 1,750,000 | $133.5M | 2026-01-22 |
Crescent Biopharma, INC. (CBIO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-12-04 | P, purchase reported on Form 4 | 1,360,000 | $18.2M | 2025-12-08 |
Spyre Therapeutics, Inc. (SYRE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Viridian Therapeutics, Inc.\DE (VRDN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Zenas BioPharma, Inc. (ZBIO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-16 | P, purchase reported on Form 4 | 300,000 | $5.1M | 2024-09-16 |
| 2025-10-07 | P, purchase reported on Form 4 | 316,219 | $6.0M | 2025-10-09 |
Dianthus Therapeutics, Inc. /DE/ (DNTH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-09-29 | P, purchase reported on Form 4 | 24,670 | $336.3K | 2023-10-03 |
Jade Biosciences, Inc. (JBIO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1663607) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms